| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2988108 | Journal of Vascular Surgery | 2015 | 9 Pages |
Abstract
Statin therapy is associated with a 5-year survival benefit after infrainguinal bypass in patients with CLI. However, 1-year limb-related outcomes were not influenced by statin use in our large observational cohort of patients undergoing revascularization in New England.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bjoern D. MD, MS, Larry W. MD, Andres MD, David H. MD, Jeffrey MD, Randall R. MD, Jack L. MD, Philip P. MD, MS, Vascular Study Group of New England Vascular Study Group of New England,